Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Iovance Biotherapeutics, Inc. IOVA

Set alert

Price alert · IOVA

All alert types
8.02 USD -0.46 -5.42%

At close · Nov 2

7.98 -0.04 -0.54%

After hours · Nov 2, 7:50 PM ET

Bid
8.00 × 1
Ask
8.01 × 1
7.66 Day range 8.56
1.81 52-week range 14.86
YTD
+193.77%
1 year
+307.11%
Open
8.53
Prev close
8.48
Mkt cap
3.63B
Vol
21.05M
Avg vol
17.24M
EPS
-0.65
P/E
0.00
Div yield
0.00%
More statistics
Low
7.66
High
8.56
Forward P/E
-40.97
Beta
0.84
Short ratio
3.26
Inst. own
70.74%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
11.37
200-d avg
5.84
1y target
14.20

5D chart

Chart tools
Interval
1m5m15m30m

Signals (134)
NameTimeAgo
SMA: BullishNov 2, 3:45 PM11 hours ago
MACD: Buy SignalNov 2, 3:45 PM11 hours ago
SMA: BullishNov 2, 3:40 PM12 hours ago
MACD: Sell SignalNov 2, 3:35 PM12 hours ago
SMA: BearishNov 2, 3:30 PM12 hours ago
SMA: BullishNov 2, 2:45 PM12 hours ago
SMA: BearishNov 2, 2:35 PM13 hours ago
SMA: BearishNov 2, 2:15 PM13 hours ago
SMA: BullishNov 2, 2:10 PM13 hours ago
MACD: Buy SignalNov 2, 2:10 PM13 hours ago
SMA: BearishNov 2, 1:25 PM14 hours ago
MACD: Sell SignalNov 2, 1:15 PM14 hours ago
SMA: BearishNov 2, 1:00 PM14 hours ago
SMA: BullishNov 2, 11:50 AM15 hours ago
SMA: BullishNov 2, 11:20 AM16 hours ago
MACD: Buy SignalNov 2, 11:05 AM16 hours ago
RSI: OversoldNov 2, 10:30 AM17 hours ago
SMA: BearishNov 2, 10:25 AM17 hours ago
SMA: BullishNov 2, 10:20 AM17 hours ago
RSI: OversoldNov 2, 10:15 AM17 hours ago

Newest 20 of 134.

Analyst view

Consensus: buy

Buy
Price target (mean) 14.20 +77.1% upside
Target (low)
7.00
Target (mean)
14.20
Target (high)
20.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy5
  • Hold2
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 9
  • 1 month ago 10
  • 2 months ago 9

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IOVA analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.08525-0.10 – -0.072-0.25+65.9%114.98M+70.5%8
Next quarter-0.08025-0.12 – -0.042-0.18+55.4%127.02M+46.4%8
Current year-0.451-0.50 – -0.408-1.09+58.6%412.73M+56.6%8
Next year-0.19575-0.42 – -0.10-0.451+56.6%593.63M+43.8%8

Upgrades and downgrades

The latest rating changes

IOVA analyst upgrades and downgrades
DateFirmActionFromTo
Oct 13, 2026BarclaysMaintainedOverweightOverweight
Oct 8, 2026BairdMaintainedNeutralNeutral
Sep 30, 2026Wells FargoMaintainedOverweightOverweight
Sep 29, 2026HC Wainwright & Co.MaintainedBuyBuy
Sep 17, 2026BarclaysMaintainedOverweightOverweight
Aug 25, 2026TD CowenMaintainedBuyBuy
Aug 20, 2026UBSMaintainedNeutralNeutral
Aug 18, 2026MizuhoMaintainedOutperformOutperform
Aug 7, 2026BarclaysMaintainedOverweightOverweight
Aug 7, 2026CitizensMaintainedMarket OutperformMarket Outperform
May 7, 2026Chardan CapitalMaintainedBuyBuy
Apr 10, 2026Chardan CapitalMaintainedBuyBuy
Mar 5, 2026UBSMaintainedNeutralNeutral
Mar 3, 2026CitizensUpgradeMarket PerformMarket Outperform
Feb 25, 2026BarclaysMaintainedOverweightOverweight
Feb 25, 2026CitizensUpgradeMarket PerformMarket Outperform
Dec 17, 2025BarclaysMaintainedOverweightOverweight
Nov 24, 2025BarclaysMaintainedOverweightOverweight
Nov 6, 2025Chardan CapitalMaintainedBuyBuy
Oct 29, 2025HC Wainwright & Co.MaintainedBuyBuy
Aug 19, 2025HC Wainwright & Co.ReiteratedBuyBuy
Aug 8, 2025Wells FargoMaintainedOverweightOverweight
Aug 8, 2025Chardan CapitalMaintainedBuyBuy
Jul 23, 2025Chardan CapitalMaintainedBuyBuy
May 16, 2025UBSDowngradeBuyNeutral
May 12, 2025Goldman SachsMaintainedBuyBuy
May 12, 2025MizuhoMaintainedOutperformOutperform
May 12, 2025BarclaysMaintainedOverweightOverweight
May 9, 2025JMP SecuritiesDowngradeMarket OutperformMarket Perform
May 9, 2025Chardan CapitalMaintainedBuyBuy